Gary Fowler and Alan Carpino: Targeted Bioscience's AI-Powered Approach in LCM

GSD Presents: Frontiers in Disease Management: Targeted Bioscience's AI-Powered Approach in LCM with Alan Carpino April 2, Tuesday Guest: Alan Carpino, CEO, Founder, Targeted BioScience https://www.linkedin.com/in/alan-carpino-820bb4121/ Before founding Targeted Biosciences, Alan was the Director of Commercial Oncology (Clinical Research/Immunotherapy Development) at Fluidigm Corporation. Prior to that, he was the Global Sales and Business Development leader for the Arcturus product line at Thermo Fisher Scientific. He is the co-author of 5 peer-reviewed publications on the use of Laser Capture Microdissection (LCM) in Personalized Medicine. #Tech #AI #HealthcareInnovation #GaryFowler #NoelGonzalez #AlanCarpino #GSD #TargetedBioscience